Remco holds a PhD in computer science. He spent the initial part of his career in academia, in Cambridge, pursuing research in computational and single-cell biology. For the last decade, Remco has led teams in AI and data science in biotech and Pharma. He has contributed to 20+ clinical compounds across indications and modalities. His teams' research work has been presented at major AI/ML conferences (ICLR, NeurIPS).